A groundbreaking new treatment makes the dreaded double chin a thing of the past.
A recent survey by the American Society for Dermatological Surgery revealed that nearly 67 percent of us are as bothered by double chins as we are by lines and wrinkles around the eyes. But while there are several options for smoothing out the crinkles, a quick fix for a shimmying chin has always proved elusive—until now.
Beauty-minded pharma company Kythera Biopharmaceuticals has debuted Kybella, the first and only FDA-approved injectable treatment for that under-the-chin wobble—or, in medical terms, submental fat. Utilizing precise injections of deoxycholic acid to destroy fat cells, Kybella, which enjoyed phenomenal success during clinical trials, has emerged as something of a miracle fix—for the appropriate patients, of course.
“In the age of the selfie, where looking good from all angles has achieved heightened importance, the jawline, chin, and neck have garnered much attention in the cosmetic world,” says Dr. Louis P. Bucky, a Philadelphia-based cosmetic surgeon.
“For the dreaded double chin, Kybella offers a nonsurgical treatment option. The best patients for this procedure have central fat just under the chin, with good skin elasticity to avoid hanging skin afterwards. We’ve seen men, in particular, excited by Kybella, which helps define a stronger jawline for them that often can’t be fixed with diet and exercise because it is genetically predisposed.” Whatever it takes to unearth your true face… Treatment programs start at $1,750. Multiple locations, 215-323-5000